MEDLON B.V.
- Company typePrivate
- Founded2011
- HeadquartersEnschede, Netherlands
- Headcount251–500
- GTM typeB2B
- OfferingServices
MEDLON B.V. firmographics
Firmographics- Name
- MEDLON B.V.
- Legal name
- Medlon B.V.
- Website
- https://medlon.nl
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
MEDLON B.V. industry classification
Industry- Product category
- Medical Laboratory Diagnostics
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071), Services-Health Services (8000)
- akta.pro primary industry
- Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK)
- akta.pro secondary industries
- Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home) (HSABACAN), Medication Reconciliation & Skilled Medication Administration (Clinical) (HSABACAH), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG)
Keywords
Where MEDLON B.V. is headquartered
LocationHeadquarters
- HQ city
- Enschede
- HQ country
- Netherlands
- HQ region
- Europe
Offices6 records
Markets served
MEDLON B.V. business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Medical laboratory diagnostics: Medlon provides medical laboratory diagnostic services (clinical chemistry, hematology, DNA testing, etc.) to patients referred by GPs, midwives, specialists, and other healthcare providers. Services are billed through Dutch health insurance under the regulated healthcare tariff framework (NZa). Revenue is generated per test request, with separate order fees and analysis charges.
- Thrombosis / anticoagulation management: Thrombosis service managing patients on vitamin K antagonists (acenocoumarol, fenprocoumon). Services include INR monitoring, dosing advice, patient self-measurement training, and dosing equipment loans. Billed through health insurance under regulated tariffs. Self-measuring patients are charged per training and control session according to NZa maximum rates.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Blood draw by Medlon staff |
| Unit Pricing | Pay-as-you-go | Blood draw by GP practice |
| Unit Pricing | Pay-as-you-go | Self-measurement training (trombosedienst) |
| Unit Pricing | Pay-as-you-go | Self-measurement control (trombosedienst) |
| Unit Pricing | Pay-as-you-go | Analysis costs (quoted per test) |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels6 records
MEDLON B.V. product offering
Product offeringCore offering
Medlon B.V. is a medical diagnostic laboratory providing clinical chemistry, haematology, urinalysis, DNA diagnostics, pharmacogenetics, and Point of Care Testing (POCT) services to healthcare providers in the Twente region of the Netherlands. It also operates a thrombosis (anticoagulation) service managing INR monitoring, dosing advice, and patient self-measurement for patients on vitamin K antagonists. Services are delivered through hospital laboratories at MST and ZGT, regional blood collection points (prikposten), home phlebotomy visits, and electronic ordering/digital patient management systems.
Product overview
Medlon B.V. is a medical diagnostic laboratory organization offering a comprehensive portfolio of diagnostic services and products. The core offerings include medical laboratory diagnostics (blood testing, urine analysis, DNA diagnostics, semen analysis) and thrombosis care (anticoagulation management with INR monitoring and dosing). The company operates Point of Care Testing (POCT) equipment including various meters for glucose, coagulation, CRP, blood gases, and other parameters. Services are delivered through hospital laboratories (MST and ZGT), blood collection points, and home phlebotomy. Medlon also provides educational courses for healthcare professionals and patients on self-measuring techniques. Since April 2018, Medlon has been part of Unilabs, an international medical diagnostics organization.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Laboratory Diagnostics
- Thrombosis Care (Trombosezorg)
- Blood Collection Services
- Home Phlebotomy (Thuisprikken)
- Point of Care Testing (POCT) Managed Service
- Pharmacogenetics Testing
- HLA Typing for Coeliac Disease
- Lactose Intolerance DNA Test
- Malaria Diagnostics (LAMP-PCR)
- NIPT (Non-Invasive Prenatal Testing)
- Holter Diagnostics
- Urine Diagnostics
- Semen Analysis
- Fecal Examination
- Blood Products Storage
- Stem Cell Processing
- Self-Measurement Training (NPT/Zelfmeten)
Quantifiable outcome
- Patient self-measuring reduces in-person clinic visits to once every 3 months after initial training period
- +2 more outcomes
Companies that use MEDLON B.V.
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles5 records
MEDLON B.V. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration11 records
Feature8 records
MEDLON B.V. partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- UnilabscoreSince April 2018, Medlon has been part of Unilabs, an international medical diagnostics organisation. This gives Medlon greater possibilities for innovation and research. Medlon is integrated into the Unilabs Netherlands structure alongside Saltro, Hudsonlab, and SHO. The thrombosis service (Unilabs Antistollingszorg) and first-line diagnostics (Unilabs Eerstelijnsdiagnostiek) are delivered under the Unilabs brand.
- SanteoncoreMedlon BV is the clinical chemistry laboratory of Medisch Spectrum Twente (MST) and belongs to the Santeon laboratory network. Santeon is a nationally operating laboratory network with a combined turnover of over €100M and 750 FTE, consisting of clinical chemistry labs at Canisius-Wilhelmina Ziekenhuis (Nijmegen), OLVG (Amsterdam), St. Antonius Ziekenhuis (Nieuwegein/Utrecht), Catharina Ziekenhuis (Eindhoven), and MST (Enschede/Medlon BV).
- Medisch Spectrum Twente (MST)coreMedlon originated in 2011 from the fusion of clinical laboratories of ZGT and MST, including the thrombosis services of both hospitals. MST is one of the Santeon hospitals. Medlon is organisationally partly part of MST and operates its laboratory services at the MST site in Enschede.
- Ziekenhuisgroep Twente (ZGT)coreMedlon provides clinical laboratory services at ZGT hospital locations in Almelo and Hengelo, and has operated the ZGT thrombosis service since 2012. Both thrombosis services (Trombosedienst MST and Trombosedienst ZGT) continue to exist under the Medlon umbrella.
- PortavitacorePortavita provides the digital dosing platform used by Medlon's thrombosis service. Patients submit INR readings via the secure Portavita web portal and receive dose recommendations the same day. The platform also manages NPT (self-measuring) for care institutions.
- LabPon (LabMicTa)minorMedlon participates in regional collaboration with diagnostic providers in Twente, including LabPon / LabMicTa, alongside LabMicTa (regional cooperation with Medlon and Menzis health insurer). Mentioned as a collaboration monitored by the Client Council.
- SHO (now part of Unilabs)minorSHO and Medlon integrated under the Unilabs Netherlands brand in 2022, following Unilabs' acquisition of SHO. Together they cover blood collection across Twente. SHO handles some specialist testing including rust-ECG (via KSYOS cardiologist reporting).
Scale indicators5 records
Recent moves9 records
Expansion highlights5 records
MEDLON B.V. competitors and assessment
Company assessmentRegional players
- Streeklaboratorium Haarlem: Streeklaboratorium Haarlem is a regional public Dutch medical microbiology and clinical laboratory serving multiple hospitals in the Kennemerland region. While focused on a different service area, it competes similarly for hospital lab outsourcing contracts in the Dutch hospital laboratory market.
Direct peers
- Atalmedial: Atalmedial is a regional Dutch medical diagnostic laboratory focused on primary care and home-based testing. Officially integrated into Unilabs in November 2023, it directly competes with Medlon in the Dutch first-line diagnostics segment and operates as a sister entity within Unilabs Nederland.
- Result Laboratorium: Result Laboratorium is an independent Dutch clinical chemistry and hematology laboratory operating primarily in the western Netherlands. It competes with Medlon for hospital laboratory outsourcing contracts and offers similar clinical chemistry, hematology, and specialized testing services.
- Saltro: Saltro is a Dutch first-line diagnostics provider serving GPs and primary-care physicians. As a fellow Unilabs Nederland entity alongside Medlon, it competes head-to-head in the same Dutch primary-care referral market with overlapping POCT and electronic ordering capabilities.
- SHO (Centraal Diagnostisch Centrum): SHO provides medical diagnostic services and blood collection throughout the Netherlands. Its Twente operations were integrated with Medlon under Unilabs in July 2022, making it the most direct operational comparator within the same geographic footprint.
Broad incumbents
- Quest Diagnostics: Quest Diagnostics is a leading US-based clinical laboratory network offering routine and specialty diagnostics at significant scale. While geographically distant, its reference-lab and pharmacogenetics offerings mirror Medlon's higher-margin specialty testing ambitions.
- Synlab: Synlab is one of Europe's largest medical diagnostic service providers, offering clinical laboratory testing across multiple countries. As the major continental-scale competitor to Unilabs, it provides relevant benchmarking for scale, lab automation, and service-line breadth in the Dutch market.
- Labcorp (Laboratory Corporation of America): Labcorp is a global clinical laboratory and diagnostics leader. Comparable to Medlon in offering routine chemistry, hematology, and specialty molecular testing, it serves as a strategic reference for portfolio breadth and integrated diagnostics models.
- Sonic Healthcare: Sonic Healthcare is an international diagnostics operator with hospital laboratory and community pathology operations across Australia, Europe (including Germany), and the US. Like Unilabs, it represents a geographically diversified incumbent laboratory platform relevant to Medlon's growth trajectory.
Others
- Eurofins Scientific: Eurofins is a global leader in laboratory testing across food, pharma, environmental, and clinical diagnostics. While broader and not a direct clinical-lab competitor in the Netherlands, it touches clinical/pharmacogenomic testing and represents an adjacent reference for laboratory operating leverage.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
MEDLON B.V. social profiles
Digital presenceMEDLON B.V. compliance and trust
Trust signalCompliance1 record
MEDLON B.V. financial estimates
Financial estimateRevenue estimate
Valuation estimate
MEDLON B.V. leadership team
Management profileNumber of profiles
Profiles2 records
MEDLON B.V. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MEDLON B.V. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MEDLON B.V.
What does MEDLON B.V. do?
Medlon B.V. is a medical diagnostic laboratory providing clinical chemistry, haematology, urinalysis, DNA diagnostics, pharmacogenetics, and Point of Care Testing (POCT) services to healthcare providers in the Twente region of the Netherlands. It also operates a thrombosis (anticoagulation) service managing INR monitoring, dosing advice, and patient self-measurement for patients on vitamin K antagonists. Services are delivered through hospital laboratories at MST and ZGT, regional blood collection points (prikposten), home phlebotomy visits, and electronic ordering/digital patient management systems.
Is MEDLON B.V. a public or private company?
MEDLON B.V. is a private company. It is classified as corporate owned and is currently operating.
When was MEDLON B.V. founded?
MEDLON B.V. was founded in 2011. It employs 251 to 500 people.
Where is MEDLON B.V. based?
MEDLON B.V. is headquartered in Enschede, Netherlands, in the Europe region.
How does MEDLON B.V. make money?
Two revenue lines are on record. Medical laboratory diagnostics are the primary driver. The others are thrombosis / anticoagulation management.
Who are MEDLON B.V.'s main competitors?
Streeklaboratorium Haarlem is listed as a regional player. Direct peers are Atalmedial, Result Laboratorium, Saltro and SHO (Centraal Diagnostisch Centrum). Broad incumbents are Quest Diagnostics, Synlab, Labcorp (Laboratory Corporation of America) and Sonic Healthcare. Eurofins Scientific is listed as an others.
Does MEDLON B.V. have an API?
No public API is recorded for MEDLON B.V..
What industry is MEDLON B.V. in?
MEDLON B.V.'s product category is Medical Laboratory Diagnostics. Its primary akta.pro industry code is HLACAPAK, Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices), with a secondary code of HSABACAN, Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home). Its NAICS code is 621511 and its SIC code is 8071.